bilastine

The drug is used for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria.

Form: tablets

ATC: R06AX29

Manufacturer: PJSC "Kyivmedpreparat"

The drug is used for the symptomatic treatment of urticaria, as well as allergic rhinoconjunctivitis (both seasonal and perennial).

Form: tablets

ATC: R06AX29

Manufacturer: JSC "Farmak" (secondary packaging, labelling, batch release from bulk product of manufacturer LABORATORIOS NORMON, S.A., Spain)

The drug is used for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria.

Form: tablets

ATC: R06AX29

Manufacturer: Vivimed Labs Ltd

The drug is used for the symptomatic treatment of urticaria, as well as seasonal and perennial allergic rhinoconjunctivitis.

Form: tablets

ATC: R06AX29

Manufacturer: AET Laboratories Private Ltd. (manufacturing of unpackaged products, primary and secondary packaging)

The drug is used for the symptomatic treatment of urticaria, as well as allergic rhinoconjunctivitis (both seasonal and perennial).

Form: tablets

ATC: R06AX29

Manufacturer: Vivimed Labs Ltd

The drug is used for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria.

Form: tablets

ATC: R06AX29

Manufacturer: FAES Pharma, S.A. (bulk manufacturing, packaging, batch control)

The drug is indicated for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria. It is also indicated for children aged 6 to 11 years weighing at least 20 kg.

Form: tablets, dispersible in the oral cavity

ATC: R06AX29

Manufacturer: A. Menarini Manufacturing Logistics and Services S.r.l. (manufacturing "in bulk", packaging, batch release, batch control)

The drug is used for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria.

Form: solution, oral

ATC: R06AX29

Manufacturer: Berlin-Chemie AG (manufacturing "in bulk", packaging, quality control and batch release)